Quality of care indicators for schizophrenia: Determinants of observed variations among Italian Departments of Mental Health. Results from the ETAS DSM study

Epidemiology and Psychiatric Sciences

Volumn 26, Issue 3, 2017, Pages 299-313

  Fantini, G ^a   Tibaldi, G ^a   Rucci, P ^b   Gibertoni, D ^b   Vezzoli, M ^c   Cifarelli, L ^d   Tiraferri, R ^e   Munizza, C ^a  

^a Centro Studi Ricerche in Psichiatria ASL TO2   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Local Health Authority   (Italy)

^d Department of Mental Health ^*  (Italy)

^e Local Health Authority   (Italy)

Author keywords

Antipsychotics; health service research; quality indicators; quality of care schizophrenia

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; FAMILY; FEMALE; GENERAL PRACTICE; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT MONITORING; PRACTICE GUIDELINE; PROPHYLAXIS; PSYCHOSOCIAL REHABILITATION; SCHIZOPHRENIA; WORK; HEALTH SERVICES RESEARCH; MENTAL HEALTH SERVICE; PROTOCOL COMPLIANCE; STANDARDS;

NEUROLEPTIC AGENT;

ANTIPSYCHOTIC AGENTS; COMMUNITY MENTAL HEALTH SERVICES; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; ITALY; MENTAL HEALTH; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC REHABILITATION; QUALITY INDICATORS, HEALTH CARE; SCHIZOPHRENIA;

EID: 84961941262     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S204579601600010X     Document Type: Article

References (26)

1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004). Consensus development conference on antipsychotic drugs and obesity. Journal of Clinical Psychiatry 65, 267-272
2. Bollini P, Pampallona S, Nieddu S, Bianco M, Tibaldi G, Munizza C (2008a). Indicators of conformance with guidelines of schizophrenia treatment in mental health services. Psychiatric Services 59, 782-791
3. Bollini P, Pampallona S, Tibaldi G, Bianco M, Nieddu S, Munizza C (2008b). Structural and organizational determinants of quality of care in patients with schizophrenia in Italy. The Journal of Nervous and Mental Disease 196, 923-926
4. Canadian Psychiatric Association (2005). Clinical practice guidelines: treatment of schizophrenia. Canadian Journal of Psychiatry 50, 1-57
5. Chou AF, Vaughn TE, McCoy KD, Doebbeling BN (2011). Implementation of evidence-based practices. Health Care Management Review 36, 4-17
6. Ferrannini L, Ghio L, Gibertoni D, Lora A, Tibaldi G, Neri G, Piazza A (2014). Thirty-five years of community psychiatry in Italy. The Journal of Nervous and Mental Disease 202, 432-439
7. Kilbourne AM, Keyser D, Pincus HA (2010). Challenges and opportunities in measuring the quality of mental health care. Canadian Journal of Psychiatry 55, 549-557
8. Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden LD, Tenhula WN, Boerescu D, Tek C, Sandson N, Steinwachs DM (2004). The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophrenia Bulletin 30, 193-217
9. Lehman AF, Steinwachs DM, Co-Investigators of the PORT Project (1998). Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24, 1-10
10. Lenroot R, Bustillo J, Lauriello J, Keith S (2003). Integrated treatment of schizophrenia. Psychiatric Services 54, 1499-1507
11. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S (2004). Physical health monitoring of patients with schizophrenia. The American Journal of Psychiatry 161, 1334-1349
12. McEvoy JP, Scheifler PL, Frances A (1999). Treatment of Schizophrenia 1999. Journal of Clinical Psychiatry 60, 1-83
13. McGorry P (2005). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry 39, 1-30
14. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000). Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatrica Scandinavica 101, 323-329
15. Munizza C, Gonella R, Pinciaroli L, Rucci P, Picci RL, Tibaldi G (2011). CMHC adherence to national mental health plan standards Italy: a survey 30 years after national reform law. Psychiatric Services 62, 1090-1093
16. National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Clinical Excellence (2002). Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. National Clinical Practice Guideline Number 1. National Institute for Health and Clinical Excellence: London
17. National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Clinical Excellence (2009). Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (update). National Clinical Practice Guideline, Number 82. British Psychological Society: Leicester, UK.
18. Nuti S, Fantini MP, Murante AM eds. (2014). Valutare i percorsi in sanita. I percorsi della salute mentale e il percorso oncologico. Un progetto della Commissione parlamentare dinchiesta del Senato sullefficienza e lefficacia del SSN. Il Mulino: Bologna
19. Nuti S, Vola F, Bonini A, Vainieri M (2016). Making governance work in the health care sector: evidence from a natural experiment in Italy. Health Economics, Policy and Law 11, 17-38
20. Rossi G, Agnetti G, Bosio R, De Luca P, Erlicher A, Morganti C, Neri G, Re E, Semisa D, Fioritti A (2014). Italian quality assurance in mental health. Journal of Nervous and Mental Disease 202, 469-472
21. Santone G, Bellantuono C, Rucci P, Picardi A, Preti A, de Girolamo G (2011). Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy. Pharmacoepidemiology and Drug Safety 20, 441-449
22. Semisa D, Casacchia M, Di MunzioW, Neri G, Buscaglia G, Burti L, Pucci C, Corlito G, Bacigalupi M, Parravani R, Roncone R, Cristofalo D, Lora A, Ruggeri M (2008). Promoting recovery of schizophrenic patients: discrepancy between routine practice and evidence. The SIEP-DIRECTS Project. Epidemiologia e Psichiatria Sociale 17, 331-348
23. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J (2011). No mental health without physical health. Lancet 377, 611
24. van Os J, Kapur S (2009). Schizophrenia. Lancet 374, 635-645
25. Weinmann S, Koesters M, Becker T (2007). Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psychiatrica Scandinavica 115, 420-433
26. Weinmann S, Roick C, Martin L, Willich S, Becker T (2010). Development of a set of schizophrenia quality indicators for integrated care. Epidemiologia e Psichiatria Sociale 19, 52-62